Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» J&J nears $7.5M deal in Risperdal case that could have cost $1.2B
J&J nears $7.5M deal in Risperdal case that could have cost $1.2B
J&J nears $7.5M deal in Risperdal case that could have cost $1.2B
Submitted by
admin
on May 19, 2015 - 11:08am
Source:
Fierce Pharma
News Tags:
JNJ
Risperdal
Headline:
J&J nears $7.5M deal in Risperdal case that could have cost $1.2B
Do Not Allow Advertisers to Use My Personal information
